Estee Lauder Companies Inc header image

Estee Lauder Companies Inc

EL

Equity

ISIN null / Valor 99350

New York Stock Exchange, Inc (2026-06-26)
USD 80.54-1.18%

Estee Lauder Companies Inc
UMushroom community rating:

star star star star star
4.00 5 votes No rating yet
NegativeNeutralPositive

About company

Estée Lauder Companies Inc. is a New York–based, publicly traded multinational beauty company that develops, manufactures and sells a broad portfolio of skincare, makeup, fragrance and hair-care products through a mix of wholesale and direct channels worldwide. Built around a collection of largely prestige and specialty brands — including names such as Estée Lauder, Clinique, M·A·C., La Mer, Jo Malone, Tom Ford Beauty, Le Labo and Aveda — the company distributes via department and specialty stores, travel retail, salons and its growing e-commerce operations, while also investing in product development, marketing and selective acquisitions to expand category reach and international footprint.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

1.91%1Y
-58.5%3Y
-74.5%5Y

Performance

49.2%1Y
48.6%3Y
44.2%5Y

Volatility

Market cap

19917 M

Market cap (USD)

Daily traded volume (Shares)

5,108,214

Daily traded volume (Shares)

1 day high/low

74.62 / 72.8

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

5 votes
Performance:
starstarstarstarstar
3.67
Innovation:
starstarstarstarstar
4.20
Society:
starstarstarstarstar
3.27
Nature:
starstarstarstarstar
3.60
Loic Aebischer
Switzerland, 16 Mar 2026
star star star star star
very nice
Sammy Siagos
United Kingdom, 24 Oct 2025
star star star star star
decent
Charles Davis
United Kingdom, 22 Oct 2025
star star star star star
Recent restructuring + focus on digital transformation

EQUITIES OF THE SAME SECTOR

FibroGen Inc
FibroGen Inc FibroGen Inc Valor: 25953994
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.32%USD 7.24
Pacira BioSciences Inc
Pacira BioSciences Inc Pacira BioSciences Inc Valor: 12338490
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.57%USD 25.24
M1 Kliniken AG
M1 Kliniken AG M1 Kliniken AG Valor: 29694419
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.94%EUR 18.90
Limes Schlosskliniken AG
Limes Schlosskliniken AG Limes Schlosskliniken AG Valor: 38625581
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.93%EUR 545.00
AbbVie Inc
AbbVie Inc AbbVie Inc Valor: 20145667
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.20%USD 253.35
NATCO Pharma Limited
NATCO Pharma Limited NATCO Pharma Limited Valor: 30461955
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.06%INR 903.45
Catalyst Pharmaceuticals Inc
Catalyst Pharmaceuticals Inc Catalyst Pharmaceuticals Inc Valor: 2649177
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.25%USD 31.50
Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc Alnylam Pharmaceuticals Inc Valor: 1806798
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.61%USD 291.37
Ligand Pharmaceuticals Inc
Ligand Pharmaceuticals Inc Ligand Pharmaceuticals Inc Valor: 12015449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.59%USD 303.59
Boston Scientific Corp
Boston Scientific Corp Boston Scientific Corp Valor: 913577
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%USD 44.23